PEAK6 Investments L.P. Has $743,000 Position in Zimmer Biomet Holdings, Inc. (ZBH)

PEAK6 Investments L.P. increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 74.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,342 shares of the medical equipment provider’s stock after purchasing an additional 2,708 shares during the quarter. PEAK6 Investments L.P.’s holdings in Zimmer Biomet were worth $743,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of ZBH. Bronfman E.L. Rothschild L.P. boosted its position in Zimmer Biomet by 25.3% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after acquiring an additional 167 shares during the period. FNY Managed Accounts LLC acquired a new stake in Zimmer Biomet during the 3rd quarter worth about $117,000. BB&T Investment Services Inc. acquired a new stake in Zimmer Biomet during the 2nd quarter worth about $144,000. Sandy Spring Bank boosted its position in Zimmer Biomet by 5.4% during the 2nd quarter. Sandy Spring Bank now owns 1,288 shares of the medical equipment provider’s stock worth $166,000 after acquiring an additional 66 shares during the period. Finally, Penserra Capital Management LLC boosted its position in Zimmer Biomet by 13.0% during the 2nd quarter. Penserra Capital Management LLC now owns 1,456 shares of the medical equipment provider’s stock worth $186,000 after acquiring an additional 168 shares during the period. 86.24% of the stock is currently owned by hedge funds and other institutional investors.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) traded up $0.29 on Thursday, reaching $115.78. The company had a trading volume of 917,100 shares, compared to its average volume of 1,356,597. Zimmer Biomet Holdings, Inc. has a 12-month low of $100.81 and a 12-month high of $133.49. The company has a current ratio of 1.47, a quick ratio of 0.78 and a debt-to-equity ratio of 0.88. The firm has a market cap of $23,383.62, a price-to-earnings ratio of 14.31, a P/E/G ratio of 1.79 and a beta of 1.15.

Zimmer Biomet (NYSE:ZBH) last posted its earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). Zimmer Biomet had a return on equity of 16.29% and a net margin of 8.36%. The company had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.83 billion. During the same quarter last year, the firm posted $1.79 earnings per share. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. research analysts expect that Zimmer Biomet Holdings, Inc. will post 8.03 EPS for the current year.

A number of brokerages have commented on ZBH. Stifel Nicolaus restated a “hold” rating and set a $120.00 price objective on shares of Zimmer Biomet in a research report on Friday, November 3rd. TheStreet lowered Zimmer Biomet from a “b-” rating to a “c+” rating in a research report on Friday, November 24th. SunTrust Banks set a $136.00 price objective on Zimmer Biomet and gave the stock a “buy” rating in a research report on Wednesday, November 1st. Piper Jaffray Companies lowered Zimmer Biomet from an “overweight” rating to a “neutral” rating in a research report on Thursday, November 2nd. Finally, Gabelli assumed coverage on Zimmer Biomet in a research report on Thursday, August 24th. They set a “buy” rating and a $142.00 price objective for the company. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $133.71.

TRADEMARK VIOLATION NOTICE: “PEAK6 Investments L.P. Has $743,000 Position in Zimmer Biomet Holdings, Inc. (ZBH)” was reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another site, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this article can be accessed at https://www.com-unik.info/2017/12/07/peak6-investments-l-p-has-743000-position-in-zimmer-biomet-holdings-inc-zbh.html.

Zimmer Biomet Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

What are top analysts saying about Zimmer Biomet Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Zimmer Biomet Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit